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INTRODUCTION 
In the last few years there has been an exponential 
development in the field of herbal medicine and these 
drugs are gaining popularity both in developing and 
developed countries because of their natural origin and 
less side effects. Momordica charantia a part of the 
Cucurbitaceae family is known as bitter melon, bitter 
gourd, balsam pear, karela, and pare. It grows in tropical 
areas of the Amazon, East Africa, Asia, India, South 
America, and Caribbean. The plant is a climbing 
permanent with elongated fruit that resembles a warty 
gourd or cucumber. The unripe fruit is white or green in 
color and has a bitter taste that becomes more 
pronounced as the fruit ripens. Momordica charantia 
contains an collection of biologically active plant 
chemicals including triterpens, proteins, steroids, 
alkaloids, saponins, flavonoids and acids due to which 
plant possesses anti-fungal, anti-bacterial, anti-parasitic, 
anti-viral, anti-fertility, anti-tumorous, hypoglycemic 
and anti-carcinogenic properties .Fruits are used as 
traditional medication to cure various diseases like: 
rheumatism, gout, worms, colic, illness of liver and 
spleen.It is also found useful in the treatment of cancer 
and diabetes. It is a potent hypoglycemic agent due to 
alkaloids and insulin like peptides and a mixture of 
steroidal sapogenins known as charantin. Diabetes 
mellitus is the one of the five important causes of death 
in the world. It is a major global health problem with a 
probable rise in prevalence from 171 million in 2000 
AD to 366 million in 2030 AD with majority still 
remaining undiagnosed. It is a syndrome of disordered 
metabolism, usually due to a combination of hereditary 
and environmental causes, resulting in abnormally high 
blood sugar levels.Etiologically, it is due to relative or 
absolute lack of insulin, the insensitivity of insulin or 
both. Momordica charantia is the most common plant 
used in alternate medicines used as anti-diabetic
1-14
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ABSTRACT 
Momordica charantia is a plant of the Cucurbitaceae family is known as bitter melon, karela, and pare. It grows in tropical 
areas of the Amazon, , Asia, South America India, East Africa and  Caribbean, and is used traditionally as both food and 
medicine. The fruit ripens, the flesh (rind) becomes slightly tougher and bitterer, and many think it too repulsive to eat. On 
the other hand, the pith becomes sweet and intensely red; it can be eaten uncooked in this state, and is a popular part in some 
Southeast Asian salads .Momordica charantia  have provided many remedies for various diseases from ancient days to now 
a day. It has been used in various Asian traditional medicines for the treatment of cholera,  anemia, diarrhea blood diseases, 
bronchitis, gout, dysentery, gonorrhea rheumatism,  ulcer, colic, worms, disease of liver and spleen, cancer and diabetes 
etc.In preliminary phytochemical analysis we observed glycosides, phytosterols, alkaloids, phenolic, saponins compounds, 
fats, proteins, and fixed oils, flavonoids, and thin layer chromatography (TLC) was also performed. The medicinal values of 
Bitter melon lies in the bioactive phytochemical constituents that are non nutritive chemicals that produce clear-cut 
physiological effects on human body and protect them from various diseases. Juice of Momordica charantia   the leaves 
used to treat piles totally. Momordica charantia   is used as a blood purifier due to its bitter tonic properties. 
Keywords: Momordica charantia, medicinal properties, pharmacology. 
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Figure 1:  Momordica charantia plant 
VERNACULAR NAME
15
 
English        Bitter gourd, Balsam pear, Balsam apple 
Nepali            Teeta Karela 
Arab                Quisaul – barri 
Assam               Kakiral, Kakral 
Bengali              Karela, Uchchhe, Kerula 
Bombay             Kurela, Jangro                                                            
Guajarati            Karela 
Hindi                   Karela, Kardi 
Kannada             Hagal                                                       
Malayalam          Kaipp, Kaippavlli, Paval 
Oria                      Kalara,      Salara 
Sanskri                 Sushavi, Karavella 
Tamil                     Pakal, Pavaka,Chedi,Paharkai 
Telgu                      Koekara, Kaaya                                            
Urdu                       Karela 
                                                                                          
SCIENTIFIC IDENTIFICATION 
Scientific name       Momordica charantia 
Kingdom                 Plantae 
Division                   Magnoliophyta 
Family                     Cucurbetaceae 
Genus                       Momordica 
Species                     charantia 
Duration                  Annual 
 
CULTIVATION  
Momordica charantia is an annual or perennial climber 
found all over India and also cultivated up to an height 
of 1500m. It is cultivated during temperate season i.e. 
during April to July by sowing seeds in a pit. Seeds are 
sown at a distance of ½ meter and provided with 
manures. Only one plant is retained and plant seedlings 
are watered once or twice a week. Plants start to flower 
30-35 days after sowing and fruits are prepared for 
harvesting after flowering 15-20 days
16, 17
. 
TRADITIONAL USED  
Momordica charantia has been used in various Asian 
traditional medicine systems for a long time, as useful 
for preventing and treating various diseases. 
Fruits:  Momordica charantia   used in asthma, 
burning sensation, constipation, colic, diabetes, cough, 
fever (malaria), gout, helminthiases, leprosy, 
inflammation, skin diseases, ulcer and wound. It has 
also been publicized to have hypoglycaemic 
(antidiabetic) properties in animal as well as human 
studies. Juice of Momordica charantia   the leaves 
used to treat piles totally. Momordica charantia   is 
used as a blood purifier due to its bitter tonic 
properties. It can heal boils and other blood related 
problems that illustrate up on the skin. Juice of 
Momordica charantia   is also beneficial in treating 
and preventing the liver damage. 
Leaves: Momordica charantia   are used in treatment 
of menstrual troubles,burning sensation, constipation, 
fever (malaria), colic,infections, worms and parasites, 
as an emmenogogue,measles,  hepatitis  and  
helminthiases. In Guyana traditional medicine, leaf tea 
is used for diabetes, to expel intestinal gas, to promote 
menstruation, and as  an antiviral for measles, 
hepatitis, and feverish condition. It is used topically for 
sores, wound, infections and internally and externally 
for worms and parasites. 
Seeds: Momordica charantia   are used in the 
treatment of ulcers, liver and spleen  problems,  
diabetes,  high cholesterol, intestinal  parasites,  and  
intestinal  gas,  heal  wounds  and stomachache etc.
 
Roots: Momordica charantia   are used in the 
treatment of syphilis, rheumatism, ulcer, boils, septic 
swellings, opthelmia, and in Prolapsusvagenae. 
Momordica charantia   juice helps to reduce the 
problem of Pyorrhea (bleeding from the gums). 
Momordica charantia   capsules and tinctures are 
widely  available  in  the  United  States  for  the 
treatment of diabetes, colds flu, viruses, tumors, 
cancer, 
 
high cholesterol and psoriasis.
 
Ethnomedical Uses:  In India, Momordica charantia  
used by tribal people for abortions, birth control, 
increasing milk flow, vaginal discharge, menstrual 
disorders, constipation, food, hyperglycemia, diabetes,  
jaundice, stones, kidney, liver, fever (malaria), eczema, 
gout,  fat loss, hemorrhoids, hydrophobia, intestinal 
parasites, skin, pneumonia ,leprosy, psoriasis, 
rheumatism, scabies, piles, snakebite, vegetables, 
anthelmintic, purgative
18-25
. 
ACTIVE CONSTITUENTS   
The main constituents of bitter melon Momordica 
charantia are triterpene, protein, steroid, alkaloid, 
inorganic, phenolic and lipid compounds
. 
Momordica 
charantia  consists the following chemical constituents 
those are alkaloids, momordicin and charine,  
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momorchanins, momordicilin, charantin, momordicius, 
momordenol, momordin, momordolol, cryptoxanthin, 
cucuritacins, cucurbitns, cycloartenols, cucuritanes, 
erythrodiol, elaeostearic acids, galacturonic acid, 
gentisic acid, goyaglycosides, goyasaponins, and 
multiflorenol, cucurbitacins, , cucurbitanes, diosgenin 
erythrodiol, guanylate cyclase inhibitors, gypsogenin, 
lauric acid, karounidiols, hydroxytryptamines, 
lanosterol, ,linoleic acid, linolenic acid, momordenol, 
momordicinin, momordicosides
28-28.
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DOSE 
Dosage recommendation depends on the form of bitter 
melon being consumed. The dose of fresh juice 
Momordica charantia  50-100 ml but it isextremely 
bitter and difficult to swallow. Although encapsulated 
dry powder is easier to consume, the standard dose is 
given 3-15 g daily– a large dose in capsule form. A 
standardized, encapsulated extract dosage ranges from 
100-200 mg three times daily
29
. 
WARNINGS AND CONTRAINDICATIONS  
Momordica charantia  seed extracts have been shown 
to induce abortion in mice and the root is a 
documented uterine stimulant, use is no recommended 
in pregnant women or those seeking pregnancy
30
. 
SIDE EFFECT AND TOXICITY  
Momordica charantia   Oral ingestion of bitter melon 
fruit is safe as demonstrated by Oral ingestion of bitter 
melon fruit is safe as demonstrated by Subcutaneous 
injection of p-insulin extracted from Momordica 
charantia  appears to be safe; however, intravenous 
injection of Momordica charantia  extracts is 
significantly more toxic and not recommended. 
Because bitter melon seeds contain momorcharin, are 
shown to have antifertility effects in female mice, 
bitter melon seed having antifertility effects in female 
mice, bitter melon seed pregnant
31
. 
PHARMACOLOICAL ACTIVITY  
Antidiabetic Activity   
Momordica charantia   contains bitter chemicals like, 
vicine, charantin, glycosides and karavilosides along 
with polypeptide-p plant insulin, which are 
hypoglycemic in action and improve blood sugar levels 
by increasing glucose uptake and glycogen synthesis in 
the liver, muscles and fat cells. Some of research 
reports indicate that they also improve insulin release 
from pancreatic beta cells, and repair or promote new 
growth of insulin-secreting beta cells. P-Insulin, a 
polypeptide from the fruits and seeds rapidly decreased 
and normalized the blood sugar level in rats. Bitter 
melon contains another bioactive compound i.e. lectin 
that has insulin like activity. The insulin-like 
bioactivity of lectin is due to its linking together 2 
insulin receptors. This lectin lowers blood glucose 
concentrations by acting on peripheral tissues and, 
similar to insulin's effects in the brain, suppressing 
appetite. This lectin is a major contributor to the 
hypoglycemic effect that develops after eating 
Momordica charantia. Charantin extracted by alcohol, 
is a potent hypoglycemic agent composed of mixed 
steroid swhich is sometimes used in the treatment of 
diabetes to lower the blood sugar levels
32-36.
 
Antimicrobial Activity  
The In vitro studies have shown bitter melon extracts 
and the MAP30 protein analog, isolated from the seeds 
of Momordica charantia extracts, possess broad-
spectrum antimicrobial activity. Momordica charantia   
extracts inhibit infection and growth of several viruses, 
including HIV, Epstein Barr virus.2 A and 24 Herpes 
simplex, preliminary report on the effect of Momordica 
charantia extract in three HIV patients showed a 
normalization of CD4/CD8 ratios with Momordica 
charantia  treatment. It is believed Momordica 
charantia   extracts inhibit HIV replication by 
preventing syncytial formation and cell-to-cell 
infection. Momordica charantia  extracts also appear 
to inhibit the growth of numerous gram-negative and 
gram-positive bacteria, including Salmonella, E. coli, 
Shigella, Staphylococcus, Pseudomonas, 
Streptococcus, Streptobacillus, & H. pylori, and 
parasitic organisms E. histolytica and Plasmodium 
falciparum
37-39
. 
Anti-Cancer Activity  
The clinical trials have not been conducted using 
Momordica charantia  extracts in cancer patients, in 
vitro studies indicate bitter melon fruit and seed 
extracts inhibit the growth of a number of cancer cell 
lines, including prostate adenocarcinoma, human colon 
cancer (Caco-2 cells), and the very much metastatic 
breast cancer cell line MDAMB 231
40-41
. 
Anti-Malarial Activity  
Momordica charantia   is traditionally regarded by 
Asians, as well as Panamanians and Colombians, as 
useful plant for preventing against used treating 
malaria. Laboratory studies have confirmed that 
various species of Momordica charantia have anti-
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malarial activity. Leaves brewed in hot water to create 
a tea to treat malaria
42
. 
Antioxidant Activity   
Momordica charantia Different parts of the plant have 
been used in the Indian medicinal system for a number 
of ailments besides diabetes. Antioxidant activity of 
extracted phenolic compound from bitter melon has 
been reported the Antioxidant properties of 
Momordica charantia Seeds on Streptozotocin 
induced-diabetic rats has been studied and results 
clearly suggest that seeds of Momordica charantia 
may effectively normalize the impaired antioxidant 
status in streptozotocin induced-diabetes
43-44
. 
Hypocholesterolemic activity  
Experiments carried out in normal as well diabetic 
animals have shown hypo-cholesterolemic effects by 
Momordica charantia.  In a study, sunflower fed rats 
were fed with conjugated octadecatrienoic fatty acid 
isolated from Momordica charantia   seeds for 4 
weeks. After 4 weeks, these rats showed significant 
lowering of the plasma lipid peroxidation and 
erythrocyte membrane lipid peroxidation as well as 
nonenzymatic liver tissue lipid peroxidation
45
. 
Immunomodulatory activity  
Immunomodulatory activity of Momordica charantia   
showed that it has a variable effect on the immune 
system in some conditions, like allograft rejection, 
someplace it was shown to have immunosuppressive 
effect and in some other cases immunostimulant. 
Immunomodulatory activity has been attributed to 
increase in interferon production and natural killer cell 
activity
46
. 
CONCLUSION 
Momordica charantia is a plant of the Cucurbitaceae 
family is known as bitter melon, karela, and pare. 
Momordica charantia have provided many remedies 
for different diseases from ancient days to now a day. 
It has been used in various Asian traditional medicines 
for the treatment of cholera, anemia, ulcer, diarrhea 
blood diseases, bronchitis, gout, dysentery, worms, 
gonorrhea rheumatism colic, disease of liver and 
spleen, cancer and diabetes etc. 
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